Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jan;7(1):123-34.
doi: 10.2217/fon.10.166.

Role of IKKα in skin squamous cell carcinomas

Eunmi Park  1 , Bigang Liu, Xiaojun Xia, Feng Zhu, Willette-Brown Jami, Yinling Hu
Affiliations
Review

Role of IKKα in skin squamous cell carcinomas

Eunmi Park et al. Future Oncol. 2011 Jan.

Abstract

Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are two major types of skin cancer derived from keratinocytes. SCC is a more aggressive type of cancer than BCC in humans. One significant difference between SCC and BCC is that SCC development is generally associated with cell dedifferentiation and morphological changes. When SCC is converted to spindle cell carcinoma, the latest stage of cancer, the tumor cells change to a fibroblastic cell morphology (epithelial-to-mesenchymal transition) and lose their differentiation markers. Recently, several laboratories have reported altered IκB kinase α (IKKα) protein localization, downregulated IKKα, and IKKα gene deletions and mutations in human SCCs of the skin, lung, esophagus, and neck and head. In addition, IKKα reduction promotes chemical carcinogen- and ultraviolet B-induced skin carcinogenesis, and IKKα deletion in keratinocytes causes spontaneous skin SCCs, but not BCCs, in mice. Thus, IKKα emerges as a bona fide skin tumor suppressor. In this article, we will discuss the role of IKKα in skin SCC development.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Keratinocytes isolated from Er (er/er) mice lack terminal differentiation marker filaggrin but express IKKα.
(A) Photos of WT, Er (er/er) and Ikkα−/− newborns stained with toluidine blue. The result indicates that the impaired skin of er/er and Ikkα−/− mice is not able to prevent water penetration. (B) Western blot compares expression of IKKβ, IKKγ and IKKα in the skin of Ikkα−/−, WT and er/er newborn mice. (C) Western blot compares terminal differentiation marker filaggrin levels in cultured er/er and Ikkα−/− keratinocytes. +IKKα: Overexpressed HA tagged IKKα (HA-IKKα) including WT, C-terminal 80-aminal acid deletion (C80); C: Control; KA: Kinase-inactive forms; WM: WT-keratinocyte culture medium (kDIF); WT: Wild-type. Reproduced from [24].
Figure 2.
Figure 2.. Nuclear IKKα function in regulating keratinocyte proliferation and differentiation.
Arrows indicate positive directions and lines present the inhibitory effect. DNA symbols represent promoter regions of genes. EGF/TPA and TGF-β in bold represent exogenous stimuli for cells. ADAM: A disintegrin and metalloprotease; TPA: 12-0-tetradecanoylphorbol-13-acetate.
See this image and copyright information in PMC

References

Bibliography

    1. Mock BA, Connelly MA, McBride OW, Kozak CA, Marcu KB: CHUK, a conserved helix-lo op-helix ubiquitous kinase, maps to human chromosome 10 and mouse chromosome 19. Genomics 27,348–351 (1995).

      ■ Identifies the human conserved helix-loop-helix ubiquitous kinase (CHUK), IκBα kinase α (IKKα).

    1. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M: A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388, 548–554 (1997).

      ■ Identifies that IKKα phosphorylates IκBs.

    1. Mercurio F, Zhu H, Murray BW et al. : IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860–866 (1997). - PubMed
    1. Rothwarf DM, Karin M: The NF-κB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci. STKE 1999, RE1 (1999). - PubMed
    1. Karin M, Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18, 621–663 (2000). - PubMed
Website
    1. National Cancer Institute. Cancer Genome Anatomy Project http://cgap.nci.nih.gov/Chromosomes/Mitelman

Publication types

Substances